Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 4/20 | 0.68 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.68 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.68 |
| ▸ | FAAH | O00519 | 12/20 | 0.49 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4897709 | 0.81 | CYP1A2 (0.55) | CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL5713209 | 0.81 | CYP1A2 (0.58) | CYP1A2CYP11B1CYP11B2CYP3A4CYP2C9 | |
| SCHEMBL11145661 | 0.79 | DGAT1 (0.47) | CYP1A2CYP11B1CYP11B2FAAHDGAT1 | |
| SCHEMBL17060555 | 0.79 | DGAT1 (0.56) | CYP1A2CYP11B1CYP11B2FAAHDGAT1 | |
| SCHEMBL9945844 | 0.79 | HTR1A (0.55) | CYP1A2CYP11B1CYP11B2MCHR1 | |
| SCHEMBL291460 | 0.77 | ANPEP (0.57) | CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL2943529 | 0.77 | ANPEP (0.57) | CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL6951241 | 0.77 | ANPEP (0.57) | CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL13998125 | 0.77 | ANPEP (0.57) | CYP1A2CYP11B1CYP11B2 | |
| SCHEMBL12472685 | 0.77 | DGAT1 (0.48) | CYP1A2CYP11B1CYP11B2FAAHDGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1268453-A1 | ESTROGEN AGONIST/ANTAGONIST METABOLITES | Pfizer Products Inc. (US) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001077093-A1 | ESTROGEN AGONIST/ANTAGONIST METABOLITES | PFIZER PRODUCTS INC. (US) | 2001-10-18 | — | — | WO | disclosed |